newsfilter
← Latest News
Business Wire·

Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance

2Q 2026 operating revenue of $49.8 billion, up 0.8% from 2Q 2025 2Q 2026 diluted EPS1 of $6.71 and adjusted diluted EPS2 of $7.45; results were supported by favorable benefit expense performance and an